Searched for
TAKEDA PHARMACEUTICAL
Takeda deepens AI drug discovery push with $1.7 billion Iambic dealIambic and Takeda Pharmaceutical have formed a multi-year partnership valued at over $1.7 billion. This collaboration will leverage artific...- TrumpRx: Japanese drugmakers slump after Trump unveils discount drug websiteShares of Japanese pharmaceutical companies fell sharply in early Tokyo trading after the launch of TrumpRx, a U.S. website offering discou...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Alkem inks licensing pact with Takeda to introduce Vonoprazan in IndiaAlkem Laboratories has entered into a patent licensing agreement with Takeda Pharmaceutical to market Vonoprazan in India. This medication ...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
- Japan's Takeda in regulatory talks to launch dengue vaccine in IndiaThe Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...
- Japan's Takeda signs MoU with BIRAC to support healthcare startupsJapanese drug maker Takeda on Tuesday entered into a three-year memorandum of understanding (MoU) with the Biotechnology Industry Research ...
- Takeda in talks to bring its dengue shot to IndiaIndia is not a part of the global Phase-3 trial of the Takeda dengue vaccine candidate, which means as per local regulation it will have to...
- Zydus Cadila partners Takeda for chikungunya vaccineCadila Healthcare said terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in...
- Alembic Pharma gets tentative nod from USFDA for FebuxostatThe product is therapeutic equivalent to the reference listed drug Uloric tablets, 40 mg, 80 mg of Takeda Pharmaceuticals USA Inc, it added.
- Dr Reddy’s Laboratories slips as Sucampo files lawsuitDr Reddy’s Laboratories were down on profit booking in early trade after Sucampo Pharmaceuticals and others filed patent infringement lawsu...
- Sun Pharmaceuticals files ANDAs for 4 products in Q1 FY14Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Cipla, Lupin shares surge in morning trade on boursesShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Japan's Takeda in $8.8 billion bid for US biotech firmJapan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...
Load More
